Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC
Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)
1 other identifier
interventional
4
1 country
1
Brief Summary
Patients with large or otherwise complex renal calculi are commonly treated by percutaneous nephrolithotomy (PNL; PERC). PERC requires the creation of an approximately 10 mm channel through the renal parenchyma, into the intra-renal collecting system, in order to effect stone fragmentation and extraction. Although the nephrostomy tract is confined to a small fraction of the renal parenchyma (approximately 1%), the trauma associated with the creation of the tract will affect blood flow and oxygen delivery to regions beyond the immediate site of injury. It is possible that this could result in a significant functional renal impairment. There are several reports describing the effect of PERC on renal function, but interpretation of these studies is difficult, due to a lack of uniformity in patient selection and variability in the timing of peri-operative evaluation. Recent data from the investigators' lab, obtained from a porcine model, suggest that, acutely, PERC causes a significant decrease in renal function as measured by para amino hippurate (PAH) clearance. The purpose of this study is to determine, in a rigorous and standardized fashion, the acute effects of PERC on renal function, as measured by nuclear renography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFebruary 23, 2016
February 1, 2016
10.8 years
September 9, 2005
February 22, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The hypothesis is that the effects of PERC anticipated on renal function will be largely resolved and the 6 week post-procedure study will not be significantly different from the pre-operative study.
One year after study completion
Study Arms (1)
cohort
OTHERInterventions
Subjects who enroll in this study will undergo a nuclear scan called a renogram to assess renal function prior to surgery (baseline), approximately one hour after surgery (to assess percutaneous effects on renal function) and finally approximately 6 weeks post-operatively (to assess return to baseline).
Eligibility Criteria
You may qualify if:
- Patients of Methodist Urology in Indianapolis, IN
- Age greater than 18 years
- Ability to provide informed consent
- Unilateral renal calculi appropriate for percutaneous removal
You may not qualify if:
- Age less than 18
- Inability to give informed consent
- Pregnant
- Renal calculi associated with infection
- Serum creatinine \> 1.4 mg/dL
- Renal obstruction
- Renal anatomic abnormality precluding accurate functional assessment using nuclear medicine techniques
- Renal duplication/anatomic abnormality (e.g., horseshoe kidney, malrotation, ectopia, etc.)
- Pre-existing diuretic therapy
- Solitary functional kidney or suspected significant differential in renal function
- Presence of diabetes, hypertension, or any other systemic disorder or medication known to affect renal function
- History of urinary tract infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IU Health Methodist Hospital
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James E Lingeman, MD
IU Health Physicians Urology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 15, 2005
Study Start
May 1, 2005
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
February 23, 2016
Record last verified: 2016-02